je.st
news
Biotech start-up aims to unlock potential of the gut-brain axis
2015-12-15 14:34:54| Biotech - Topix.net
Kallyope Inc. is aiming to harness the potential of the gut-brain axis to develop consumer products and transformational therapeutics that improve human health and nutrition. The biotech company announced $44 million of Series A financing last week, and boasts numerous members of the national academies, two Lasker Award winners, and three Nobel laureates among its founders and scientific advisory board.
Tags: potential
aims
axis
biotech
Category:Biotechnology and Pharmaceuticals